September 8, 2017

Biotech startup gets $3 million grant for HIV research

This article originally appeared on Ithaca Journal.

A biotech company in Ithaca has received a $3 million grant the company will use to hire five to 10 employees within the next year.

Jan Biotech, Inc. received the grant co-funded through the National Institute of Allergy and Infectious Disease and the National Institute of Mental Health, within the National Institutes of Health, said Janet Huie, chief scientific officer and co-founder of Jan Biotech, Inc. The business received the grant for its work in HIV research.

Jan Biotech is a privately-held company focused on supporting the cure of infectious diseases and cancers to improve human, animal and environmental health. Huie said the company’s cell-based HIV assay platform will be the first of its kind to accurately detect and quantify groups of infected cells not actively producing HIV, known as latent HIV-infected reservoirs, in HIV-infected patients undergoing treatment.

Read the full article>>